Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
http://www.nature.com/articles/7700988.pdf
Reference49 articles.
1. Rougier P, Bugat R, Douillard JY, Culine S, Suc E, Brunet P et al. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 1997; 15: 251–260.
2. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22: 229–237.
3. de Gramont A, Tournigand C, Louvet C, Maindrault-Goebel F, Andre T . First-line therapy for advanced colorectal cancer. Curr Oncol Rep 2005; 7: 167–172.
4. McCormick F . Cancer-specific viruses and the development of ONYX-015. Cancer Biol Ther 2003; 2: S157–S160.
5. Kirn DH, McCormick F . Replicating viruses as selective cancer therapeutics. Mol Med Today 1996; 2: 519–527.
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?;Molecular Therapy - Oncolytics;2022-03
2. Methods for Modification of Therapeutic Viruses;Methods in Molecular Biology;2019-09-05
3. Microbubble-mediated delivery of human adenoviruses does not elicit innate and adaptive immunity response in an immunocompetent mouse model of prostate cancer;Journal of Translational Medicine;2019-01-11
4. A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs);OncoImmunology;2018-07-23
5. Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control;Nature Communications;2018-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3